The advisory committee voted to return six peptides barred in 2023, over FDA staff objections. The author argues the GLP-1 shortage proved compounders can deliver.
Recap by typeshit. Full story at Independent Institute.
A lawyer named Jeff walks through how his side argues Ozempic, Wegovy and other semaglutide drugs may be linked to NAION, a serious form of sudden vision loss.
Stavros Nicolaou of the Pharmaceutical Task Group wants police to act. SAHPRA says it has seized products and opened criminal cases.
The physician group is pushing back on an FDA plan that would open interim access to unapproved peptides, and wants the White House to block it.
Investigators turned up a warehouse of empty pens and a farm building used as a drug factory, as counterfeit weight loss injection sellers grow more organized.
At 52 weeks, Lilly reports 1.5% more weight loss on 17.2 mg Foundayo, but the data compares two separate trials rather than a head-to-head study.
A consumer review of Lemonaid's telehealth weight loss service, which manages GLP-1 injections and prescriptions for patients paying out of pocket.
Loading…